Company Search:
Advanced Search
Sponsored Links
Kalvista Pharmaceuticals Inc Company Snapshot
Kalvista Pharmaceuticals Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kalvista Pharmaceuticals Inc with three other companies in this sector in UNITED STATES : Inhibrx Inc (2020 sales of $12.89 million of which 100% was Biologic therapeutic candidates), Kempharm Inc ($13.29 million of which 100% was Pharmaceutical company), and Ovid Therapeutics Inc ($12.62 million of which 100% was purposes of assessing performance).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Kalvista Pharmaceuticals Inc
  Stock Performance Chart for Kalvista Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (4/16/2021): 24.45
(Figures in U.S. Dollars)
1 Week -6.5%   13 Weeks -24.5%  
4 Weeks 40.6%   52 Weeks 120.1%  
Kalvista Pharmaceuticals Inc Key Data:
  Ticker: KALV Country: United States
  Exchanges: NAS Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 12,690,000
(Year Ending Jan 2021).
Employees: 56
  Currency: U.S. Dollars Market Cap: 440,618,927
  Fiscal Yr Ends: April Shares Outstanding: 18,021,224
  Share Type: Common Closely Held Shares: 1,653,645
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.